WebJan 23, 2024 · Eligible for carboplatin and paclitaxel chemotherapy in accordance with local standards of care A female participant is eligible to participate if she is not pregnant (see Appendix 3), not breastfeeding, and at least one of the following conditions applies: Not a woman of childbearing potential (WOCBP) as defined in Appendix 3 OR WebMar 15, 2024 · A randomized multicenter phase III study comparing weekly versus every 3-week carboplatin plus paclitaxel in patients with advanced ovarian cancer …
Carboplatin - NCI - National Cancer Institute
WebEighteen months after the start of atezolizumab, the patient was treated with carboplatin, nab-paclitaxel, and pembrolizumab as fourth-line therapy. ... Consent for Publication. … WebPaclitaxel is used to treat different cancers, including ovarian, breast and non-small cell lung cancer. It may also be used to treat other cancers. It is best to read this information with our general information about chemotherapy and the type of cancer you have. smoke illicit lyrics
Design and Characterization of Carboplatin and Paclitaxel …
WebResults: RP2D for Arm A (n = 10) was ipatasertib 300 mg daily, carboplatin AUC2, and paclitaxel 80 mg m-2 days 1, 8, and 15 every 28 days. RP2D for Arm B (n = 12) was ipatasertib 400 mg daily and carboplatin AUC2 days 1, 8, and 15 every 28 days. RP2D for Arm C (n = 6) was likely ipatasertib 300 mg 21 days on 7 days off, capecitabine 750 mg … WebFeb 14, 2024 · Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial ... Adverse events were collected by investigators from the time of informed consent until 30 days after the last dose of study treatment and ... WebPaclitaxel and carboplatin is used to treat lung, ovarian, womb and cervical cancer. It may sometimes be used to treat other cancers. It may sometimes be used to treat other … riverside house cheltenham hospital